NCT05674877View on ClinicalTrials.gov

Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resection

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

June 28, 2023

Study Completion Date

July 30, 2023

Conditions
Liver Cirrhosis
Interventions
DRUG

Opioid-based group (OB) (placebo/saline)

Patients in the opioid-based group will receive placebo boluses and infusions of saline.

DRUG

"Opioid sparing group (OS) (dexmedetomidine (PRECEDEX™ dexmedetomidine hydrochloride - Pfizer) and ketamine)"

"Patients in the Opioid Sparing group will receive a dexmedetomidine (PRECEDEX™ dexmedetomidine hydrochloride - Pfizer) and ketamine."

Trial Locations (1)

Unknown

National Liver Institute, Menoufia University, Shibīn al Kawm

All Listed Sponsors
lead

Cairo University

OTHER